MedPath

Viral and Host Factors in the Transmission and Pathogenesis of HIV

Terminated
Conditions
HIV Infections
Registration Number
NCT00219947
Lead Sponsor
Rockefeller University
Brief Summary

To study the collection of blood from individuals known to be at high risk for HIV-infection or who have been recently infected with HIV.

The data collected are used for diagnostic, prognostic and management decisions as outlined by current HIV-1 Treatment Guidelines.

Detailed Description

This phlebotomy protocol permits the collection of blood from individuals known to be at high risk for HIV-infection or who have been recently infected with HIV.

Participants will have from 10 to 60 ml (approximately 1 to 4 tablespoons) of blood drawn for one or all of the following tests:

* T cell subset enumeration

* Serologic reactivity with HIV antigens

* Viral load assays by bDNA, PCR, or RT-PCR

* Routine Laboratory assessments (chemistries, liver function tests, hepatitis serology, RPR)

* HIV-1 Resistance Testing

These data are used for diagnostic, prognostic and management decisions as outlined by current HIV-1 Treatment Guidelines

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
600
Inclusion Criteria

recently infected with HIV-1 HIV-1 negative, and at high risk for infection

Exclusion Criteria

none

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Participants are tested for HIV-1 RNA levels, the presence of antibodies to HIV antigens, and T cell subsetsfirst visit
Secondary Outcome Measures
NameTimeMethod
Data will be used for diagnostic, prognostic and management decisions as outlined by current HIV-1 Treatmentfirst visit

Trial Locations

Locations (2)

Aaron Diamond AIDS Research Center (ADARC)

🇺🇸

New York, New York, United States

Rockefeller University Hospital

🇺🇸

New York, New York, United States

Aaron Diamond AIDS Research Center (ADARC)
🇺🇸New York, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.